You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

392 Results
Drug
Other Name(s): Gleevec®
Dec 2024
Drug
Other Name(s): Tomudex®
Sep 2024
Drug
Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™
Jun 2025
Drug
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Drug
Other Name(s): Yervoy®
Aug 2024
Drug
Other Name(s): Jakavi®
Mar 2025
Drug
Other Name(s): Stivarga®
Nov 2023
Drug
Other Name(s): Istodax®
Mar 2023
Drug
Other Name(s): Cyramza®
Mar 2023
Drug
Other Name(s): Zydelig™
Feb 2022
Drug
Other Name(s): Ninlaro™
Jun 2019
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Oct 2024

Pages